Merck's Latest $2.7-Billion Buy Of ArQule Brings About Precision Targeted And Diversified Approach To Cancer TherapySeeking Alpha • 12/16/19
Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020Investors Business Daily • 12/13/19
Shares of cancer-treatment company ArQule surge 100 percent on Merck acquisitionNew York Post • 12/09/19